USPSTF recommends PrEP using effective antiretroviral therapy in adults and adolescents at high risk for HIV.
Where this comes from
- Record sourced from PubMed, PMID 38048576.
- Also identified by DOI 10.7326/J23-0094.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
US Preventive Services Task Force; Barry MJ, Nicholson WK, Silverstein M, et al. <b>Preexposure prophylaxis to prevent acquisition of HIV: US Preventive Services Task Force Recommendation Statement.</b> JAMA. 2023;330:736-745. 37606666.
Medical subject headings
- HIV Infections
- Pre-Exposure Prophylaxis